1. Home
  2. SLS vs DM Comparison

SLS vs DM Comparison

Compare SLS & DM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • DM
  • Stock Information
  • Founded
  • SLS 2012
  • DM 2015
  • Country
  • SLS United States
  • DM United States
  • Employees
  • SLS N/A
  • DM N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • DM Industrial Machinery/Components
  • Sector
  • SLS Health Care
  • DM Technology
  • Exchange
  • SLS Nasdaq
  • DM Nasdaq
  • Market Cap
  • SLS 89.6M
  • DM 87.7M
  • IPO Year
  • SLS N/A
  • DM N/A
  • Fundamental
  • Price
  • SLS $1.09
  • DM $4.98
  • Analyst Decision
  • SLS
  • DM Hold
  • Analyst Count
  • SLS 0
  • DM 1
  • Target Price
  • SLS N/A
  • DM $5.50
  • AVG Volume (30 Days)
  • SLS 815.8K
  • DM 3.4M
  • Earning Date
  • SLS 03-20-2025
  • DM 05-08-2025
  • Dividend Yield
  • SLS N/A
  • DM N/A
  • EPS Growth
  • SLS N/A
  • DM N/A
  • EPS
  • SLS N/A
  • DM N/A
  • Revenue
  • SLS N/A
  • DM $168,283,000.00
  • Revenue This Year
  • SLS N/A
  • DM N/A
  • Revenue Next Year
  • SLS N/A
  • DM $6.25
  • P/E Ratio
  • SLS N/A
  • DM N/A
  • Revenue Growth
  • SLS N/A
  • DM N/A
  • 52 Week Low
  • SLS $0.77
  • DM $1.84
  • 52 Week High
  • SLS $1.84
  • DM $11.80
  • Technical
  • Relative Strength Index (RSI)
  • SLS 40.56
  • DM 79.89
  • Support Level
  • SLS $1.13
  • DM $2.18
  • Resistance Level
  • SLS $1.25
  • DM $5.09
  • Average True Range (ATR)
  • SLS 0.07
  • DM 0.28
  • MACD
  • SLS -0.01
  • DM 0.29
  • Stochastic Oscillator
  • SLS 17.39
  • DM 96.51

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About DM Desktop Metal Inc.

Desktop Metal Inc manufactures 3D printing to make metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers. 3D metal printing helps in the design and development of automotive parts, consumer goods, manufacture of industrial equipment, and design of mechanical systems. The company ships its product to markets in the Americas, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It derives maximum revenue from Americas.

Share on Social Networks: